Groundbreaking innovation combines SunTech‘s cuff-based blood pressure with Valencell’s PPG-based blood pressure monitoring technology
New technology set to transform patient safety, care, and comfort
Morrisville, NC (February 8th, 2021) SunTech Medical Inc., the leading provider of clinical-grade blood pressure (BP) measurement technologies and devices, and Valencell Inc., the leader in highly accurate biometric sensors for wearables, today announce proof of concept for DeltaTrak™ technology. The patent-pending innovation combines the gold-standard accuracy of SunTech’s Advantage™ cuff-based BP and its superior motion tolerance capabilities, with continuous interpolative BP monitoring from Valencell’s optical PPG (photoplethysmography) technology between cuff readings. The proof of concept will allow for joint development discussions with medical device manufacturers interested in integrating this capability into their products.